The link between rheumatic diseases and cancer
More details
Hide details
Online publication date: 2013-04-29
Reumatologia 2013;51(2):151–155
Cancer is one of the main causes of mortality in the world today.
In addition to clinical signs characterizing the different types of proliferative diseases, they can be present in the form of paraneoplastic syndrome (PS). Among the forms of PS are rheumatic symptoms, which may suggest the diagnosis of cancer, or predispose to its development. The authors present the most common symptoms of rheumatic diseases in the course of cancer, and discuss the issue of predisposition to the development of proliferative disease in patients with various rheumatic diseases. In this paper the authors also describe the main pathomechanisms that may lead to the emergence of paraneoplastic syndromes.
Ociepa-Zawal M, Puszczewicz M. Objawy reumatologiczne w przebiegu chorób nowotworowych. W: Reumatologia. Wielka interna. Puszczewicz M (red.) Medical Tribune Polska, Warszawa 2010; 502-511.
Yazici Y, Kagen LJ. The association of malignancy with myositis. Curr Opin Rheum 2000; 12: 498-500.
Marmur R, Kagen L. Zespoły nerwowo-mięśniowo-szkieletowe związane z chorobą nowotworową. Medycyna po Dyplomie 2002; 11: 65-75.
Chmielarczyk-Koszykowska I. Zespół paranowotworowy w reumatologii. Reumatologia 2001; 39: 395-402.
Whitmore SE, Rosenshein NB, Provost TT. Ovarian cancer in patients with dermatomyositis. Medicine 1994; 73: 153-160.
Maoz CR, Langevitz P, Livneh A, et al. High incidence of malignancies in patients with dermatomyositis and polymyositis: an 11-year analysis. Semin Arthritis Rheum 1998; 27: 319-324.
Dąbrowska-Zimoń A, Brzosko M. Reumatologiczne para­­nowo­tworowe – przegląd literatury. Roczniki Pomorskiej AM w Szczecinie 2006; 52 supl. 2: 17-22.
Yoe J, Gause BL, Curti BD, et al. Development of rheumatoid arthritis after treatment of large granular lymphocyte leukemia with deoxycoformycin. Am J Hematol 1998; 57: 253-257.
Rosenthal AK, McLaughlin JK, Gridley G, Nyrén O. Incidence of cancer among patients with systemic sclerosis. Cancer 1995; 76: 910-914.
Kyndt X, Hebbar M, Queyrel V, et al. Systemic scleroderma and cancer. Search for predictive factors of cancer in 123 patients with scleroderma. Rev Med Interne 1997; 18: 528-532.
Yazici Y, Kagen LJ. Malignancy and rheumatic disorders. Available at: http://www.uptodate.com. Accessd May 28, 2001.
Tishler M, Shoenfeld Y. Paraneoplastic syndromes. In: Cancer and autoimmunity. Elsevier, Amsterdam 2000; 121-133.
Pazdur J. Objawy tzw. reumatyczne towarzyszące chorobom rozrostowym. W: Reumatologia kliniczna. Chwalińska-Sadowska H (red.). DOCEO, Warszawa 1995; 174.
Mody GM, Cassim B. Rheumatologic features of hematologic disorders. Curr Opin Rheum 1996; 8: 57-61.
Ravindran V, Anoop P. Rheumatologic manifestations of benign and malignant haematological disorders. Clin Rheumatol 2011; 30: 1143-1149.
McCarty DJ, O’Duffy JD, Pearson L, Hunter JB. Remitting seronegative symmetrical synovitis with pitting edema. RS3PE syndrome. JAMA 1985; 254: 2763-2767.
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.